Viking Global's $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo ...

Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...

The start-up is making antivirals and cancer drugs for Big Pharma—and working to treat reproductive problems on its own ...

Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment ...

Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...

During his remarks to military leaders at Marine Corps Base Quantico several weeks ago, Donald Trump ranted about the Gulf of Mexico (or the Gulf of America, according to him). He falsely claimed that ...

Novo Nordisk and Pfizer's multibillion-dollar fight over who gets to buy an anti-obesity biotech has morphed into a narrative ...

Stock index futures jump on reports of Senate breakthrough to end shutdown. Taiwan Semi's October revenue rises 17% YoY, ...

You cannot know the power of an investment unless you see the returns. Many think of dividend stocks as a way of generating ...

A spokesperson in Gov. Ned Lamont's administration did not rule out the state making available a nearly 125-acre tract for ...

Metsera's lead pipeline asset is MET-097i, a GLP-1 receptor agonist designed for once-monthly injection. Novo's weight-loss drugs Wegovy and Eli Lilly's Zepbound and Mounjaro require weekly injections ...

How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are ...